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Abstract. Background: The most common mechanism that
reduces the efficacy of anticancer agents is overexpression of
ATP-binding cassette (ABC) drug transporters. Phenothiazines
and structurally-related compounds can sensitize multidrug-
resistant (MDR) cells to chemotherapeutics. Materials and
Methods: Phenothiazine derivatives were investigated
regarding their anticancer and MDR-reversing effect on
colonic adenocarcinoma cells. The anti-proliferative and
cytotoxic effects of the derivatives were assessed by the
thiazolyl blue tetrazolium bromide (MTT) method, the
modulation of the ABCB1 activity was measured by rhodamine
123 accumulation assay using flow cytometry. Results: All
phenothiazines exhibited potent cytotoxic effect on the sensitive
and MDR colon adenocarcinoma cell lines. The inhibition of
the ABCB1 transporter was greater in the presence of the
phenothiazine derivatives than for the known ABCB1 inhibitor
verapamil. Conclusion: It can be concluded that these
derivatives show synergism in the presence of doxorubicin and
could have potential as ABCB1 inhibitors.
Colorectal cancer is a common malignancy and despite surgical
and chemotherapeutic treatments, it is still the second leading
cause of cancer-related deaths in Western Europe, North
America, Australia and New Zealand (1, 2). The resistance of
tumor cells to cytostatic, structurally unrelated drugs that do
not have a common mechanism of action is a phenomenon
described as multidrug resistance (MDR) (3). A number of
cellular mechanisms are responsible for the MDR of cancer
cells. The most common mechanism that reduces the efficacy
of anticancer agents is the overexpression of ATP-binding
cassette drug transporters (4). Phenothiazines have anticancer
properties and are able to reverse the MDR of neoplastic cells
by inhibiting the activity of ATP-binding cassette, sub-family
B, member 1 protein (ABCB1 or P-glycoprotein) (4).
Previously, 26 new phenothiazine derivatives were
synthesized and studied for anticancer activity (6, 7). All 26
phenothiazines had potent anti-proliferative and cytotoxic
effects, furthermore, they inhibited the activity of the ABCB1
transporter (P-glycoprotein), and this inhibition was greater
than that of the well-known ABCB1 inhibitors thioridazine
and verapamil (6).
In the present study, these 26 phenothiazine derivatives
were investigated regarding their ABCB1-modulating and
apoptosis-inducing properties against MDR colonic
adenocarcinoma cells overexpressing the ABCB1 pump. In
addition, the most active derivatives were combined with the
chemotherapeutic drug doxorubicin and their interaction was
studied in MDR colonic adenocarcinoma cells.
Materials and Methods
Cell lines. Human colonic adenocarcinoma cell lines (Colo 205
doxorubicin-sensitive parent and Colo 320/MDR-LRP multidrug-
resistant overexpressing ABCB1 (MDR1)-LRP), ATCC-CCL-220.1
(Colo 320) and CCL-222 (Colo 205) were purchased from LGC
Promochem, Teddington, UK.
The cells were cultured in RPMI-1640 medium supplemented
with 10% heat-inactivated fetal bovine serum, 2 mM L-glutamine, 
1 mM Na-pyruvate and 100 mM Hepes. The cell lines were
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Figure 1. Structures of N-hydroxyalkyl-2-aminophenothiazines (1a-o, 2, 3). Commonly, R’ is OCH3, except 1e, where R’ is morpholine.
incubated in a humidified atmosphere (5% CO2, 95% air) at 37˚C.
The semi-adherent human colon cancer cells were detached with
0.25% trypsin and 0.02% EDTA for 5 min at 37˚C.
Compounds. Chemical structures of the previously tested
phenothiazine derivatives are shown in Figure 1 (8). The
compounds were prepared by recently elaborated chemical
transformations (7). Thus, derivatives 1a-o were obtained by
protection and Buchwald-Hartwig amination of 1, R=Cl whereas 2
was obtained as a by-product of the hydroboration-oxidation
transformation of the appropriately substituted dienylphenothiazine.
Sulfoxides 3a-e and sulfones 3f-j were prepared by oxidation of
the related phenothiazine 1 with m-chloroperoxybenzoic acid (m-
CPBA). The phenothiazine derivatives were dissolved in dimethyl
sulfoxide (DMSO; Sigma-Aldrich, Madrid, Spain).
Assay for antiproliferative and cytotoxic effect. The effects of
increasing concentrations of the drugs alone on cell growth were
tested in 96-well flat-bottomed microtiter plates. The compounds
were diluted in a volume of 100 μl medium. Then, 5×103 (for
antiproliferative assay) or 2×104 cells (for cytotoxic assay) in 50 μl
of medium, respectively, were added to each well, with the
exception of the medium control wells. The culture plates were
further incubated at 37˚C for 24 and 72 h, respectively; at the end of
the incubation period, 15 μl of MTT (thiazolyl blue tetrazolium
bromide, Sigma) solution (from a 5 mg/ml stock) was added to each
well. After incubation at 37˚C for 4 h, 100 μl of sodium dodecyl
sulfate (SDS) (Sigma) solution (10% in 0.01 M HCI) was added to
each well and the plates were further incubated at 37˚C overnight.
Cell growth was determined by measuring the optical density (OD)
at 540 nm (ref. 630 nm) with a Multiscan EX ELISA reader
(Thermo Labsystems, Cheshire, WA, USA).
Inhibition of cell growth was determined according to the formula:
Where IC50 is defined as the inhibitory dose that reduces the growth
of the cells exposed to the compound by 50%.
Flow cytometric assay for evaluation of the effects a compound on
the retention of rhodamine 123 by ABCB1 (P-glycoprotein) in
tumor cells. This assay has been fully-described previously (8).
Briefly, the cells were adjusted to a density of 2×106/ml, re-
suspended in serum-free RPMI-1640 medium and distributed in
0.5 ml aliquots into Eppendorf centrifuge tubes. Test compounds
(10 μl) were added at different concentrations, and the samples
were incubated for 10 min at room temperature. Next, 10 μl (5.2
μM final concentration) of rhodamine 123 was added to the
samples and the cells were incubated for a further 20 minutes at
37˚C, washed twice and re-suspended in 0.5 ml phosphate-
buffered saline (PBS) for analysis. The fluorescence uptake of the
cell population was measured with a Partec CyFlow flow
cytometer (Partec, Münster, Germany). Verapamil was used at 20
μM as a positive control in the rhodamine 123 exclusion
experiments. The mean fluorescence intensity (%) was calculated
for the treated MDR Colo 320 and sensitive Colo 205 cell lines as
compared to untreated cells. A fluorescence activity ratio (FAR)
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Figure 2. Rhodamine 123 retention in the presence of the most effective phenothiazine derivatives at 2 μM and verapamil at 20 μM as positive
control on multidrug-resistant colonic adenocarcinoma cells (Colo 320).
was calculated via the following equation, on the basis of the
measured fluorescence values:
Apoptosis assay. The assay was carried out using Annexin V-FITC
Apoptosis Detection Kit (Calbiochem, Merck KGaA, Darmstadt,
Germany) according to the manufacturer's instructions. The density
of the MDR colonic adenocarcinoma cell suspension was adjusted
to approximately 1×106 cells/ml. The cell suspension was
distributed into 0.5 ml aliquots (5×105 cells) to a 24-well microplate
and incubated overnight at 37˚C with 5% CO2.
On the following day, the medium was removed and fresh medium
was added to the cells. The cells were incubated in the absence and
presence of the compounds for 3 h at 37˚C, compound 12H-
benzo[α]phenothiazine (M627) was used as positive control at a final
concentration of 20 μM (9). The culture medium was removed, the
cells were washed with PBS and fresh medium was added to the cells.
The 24-well plates were incubated overnight at 37˚C with 5% CO2.
After the incubation period, the cells were removed gently from each
well using a cell scraper, then centrifuged at 2000 ×g for 2 min at
room temperature, the supernatant was removed and the cells were
re-suspended in fresh serum-free medium. 
After this procedure, the apoptosis assay was carried out according
to the rapid protocol of the kit. The fluorescence was analyzed
immediately using a Partec CyFlow flow cytometer (Partec).
Checkerboard combination assay. A checkerboard microplate
method was applied to study the effect of drug interactions between
phenothiazine derivatives and the chemotherapeutic drug
doxorubicin on MDR colonic adenocarcinoma cells overexpressing
the ABCB1 transporter.
The dilutions of doxorubicin were made in a horizontal
direction in 100 μl, and the dilutions of the phenothiazines
vertically in the microtiter plate in 50 μl volume. The cells were
re-suspended in culture medium and distributed into each well in
50 μl containing 1×104 cells. The plates were incubated for 72 h at
37˚C in a CO2 incubator. The cell growth rate was determined
after MTT staining, as described above. Combination index (CI)
values at 50% of the growth inhibition dose (ED50), were
determined using CompuSyn software (www.combosyn.com,
ComboSyn, Inc., Paramus, NJ. 07652 USA) to plot four to five
data points to each ratio. CI values were calculated by means of
the median-effect equation (10), where CI<1, CI=1, and CI>1
represent synergism, additive effect (or no interaction), and
antagonism, respectively (10).
Results
The phenothiazine derivatives exhibited more potent
cytotoxic effects on the resistant colon adenocarcinoma cells
than on the sensitive Colo 205 cell line. The IC50 values of
the derivatives on the sensitive Colo 205 cell line can be
divided into four groups: with IC50 of more than 100 μM:
1i, 3f, 3g, 3h, 3i; IC50 of between 20 and 55 μM: 1a, 1b, 1d,
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Table I. Antiproliferative and cytotoxic activity of phenothiazines on
multidrug-resistant Colo 320 colon adenocarcinoma cells.
Antiproliferative effect Cytotoxic effect
Derivative IC50 (μM) SD IC50 (μM) SD
1a 14.83 1.15 6.97 0.50
1b 12.85 1.45 6.56 0.28
1c 7.29 0.57 6.49 0.87
1d 38.85 1.42 8.46 0.06
1e 18.64 0.40 6.11 0.08
1f 21.58 1.82 6.59 0.33
1g 25.16 0.53 6.60 0.52
1h 3.325 0.19 2.92 0.08
1i 41.49 1.46 5.42 0.27
1j 7.50 0.95 5.03 0.39
1k 2.83 0.24 2.52 0.20
1l 11.24 2.60 6.09 0.30
1m 3.60 0.16 6.56 0.47
1n 3.43 0.25 7.73 0.17
1o 2.90 0.62 4.53 0.19
2 3.88 0.14 5.25 0.96
3a 16.91 1.79 6.56 0.19
3b 2.71 0.09 5.79 0.29
3c 3.02 0.11 7.71 0.66
3d 3.09 0.23 5.99 0.08
3e 3.07 0.09 7.32 1.54
3f 4.02 0.23 5.91 0.46
3g 2.83 0.04 6.14 0.86
3h 2.89 0.17 6.70 0.57
3i 4.67 0.13 8.73 0.04
3j 3.59 0.33 4.98 0.31
DMSO (v/v%) 2.19 0.06 2.69 0.04
IC50: Half-maximal inhibitory concentration; SD: standard deviation;
v/v%: volume solute per volume of total solution after mixing.
Table II. Type of interaction between phenothiazine derivatives and
doxorubicin against multidrug resistant (MDR) colonic adenocarcinoma
(Colo 320) cells 
Derivative Ratioa CIb Interaction
1c 12:1 0.31 Synergism
3d 12:1 0.14 Strong synergism
3g 12:1 0.17 Strong synergism
3h 12:1 0.11 Strong synergism
3i 12:1 0.10 Strong synergism
3j 12:1 0.29 Strong synergism
aData are shown as the best combination ratio between the tested
compounds and doxorubicin. bCombination index (CI) values at the
50% growth inhibition dose (ED50) were determined by the CompuSyn
software to plot four to five data points at each ratio. CI values were
calculated by means of the median-effect equation, where CI<1, CI=1
and CI>1 represent synergism, additive effect (i.e., no interaction), and
antagonism, respectively.
1f, 1g, 1l, 1n, 3a, 3b, 3c, 3e; IC50 of between 10 and 19 μM:
1c, 1j, 1m, 2, 3d, 3j; and IC50 of between 5 and 9 μM: 1e,
1h, 1k. The compounds were more selective for the MDR
Colo 320 cells, as shown by their lower IC50 values. Based
on the IC50, the compounds can be divided into three
categories: with IC50 of between 10 and 40 μM: 1a, 1b, 1d,
1e, 1f, 1g, 1i, 1l, 3a; IC50 of between 3 and 10 μM: 1c, 1h,
1j, 1m, 1n, 2, 3c, 3d, 3e, 3f, 3i, 3j; and IC50 of less than 
3 μM: 1k, 1o, 3b, 3g, 3h (Table I).
The phenothiazine derivatives showed more potent
cytotoxic effects on the resistant colonic adenocarcinoma
cells than on the sensitive Colo 205 cell line. The
phenothiazine derivatives 1n, 3b, 3c, 3g, 3h, and 3i had no
cytotoxic effect on the sensitive Colo 205 cells because
their IC50 values were above 100 μM. The derivatives 1f,
1l, 3d, and 3f inhibited the growth of Colo 205 cells to a
certain extent (IC50 between 40 and 50 μM). Furthermore,
derivatives 1a, 1c, 1e, 1g, 1m, 1o, 2, 3a, 3f, and 3j had
potent cytotoxic activity (IC50 between 15 and 30 μM). The
most active derivatives had IC50 values between 4 and 15
μM: 1b, 1d, 1h, 1i, 1j, 1k (data not shown). Interestingly,
the phenothiazine derivatives exerted more potent cytotoxic
activity against the ABCB1-expressing MDR colonic
adenocarcinoma cells, suggesting that the compounds may
act on the ABCB1 transporter. The cytotoxic activity of the
compounds expressed as the IC50 ranged between 2.5 and 9
μM, the most active derivative being 1k (IC50=2.5 μM)
(Table I).
Out of the 26 phenothiazine derivatives, 13 (1a-c, 1f, 1g,
1m, 2, 3d, 3f-j) demonstrated potent ABCB1-modulating
effect because these compounds increased the intracellular
rhodamine 123 concentration of the MDR colonic
adenocarcinoma cells at 2 and 20 μM. As shown in Figure
2, the most active derivatives induced rhodamine 123
accumulation at 2 μM compared to ABCB1 modulator
verapamil at 20 μM (FAR=10.7). It is noteworthy that out of
the 13 ABCB1-modulating phenothiazine derivatives, only
compound 3j was able to induce apoptosis of MDR colonic
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Figure 3. Apoptosis induction in Colo 320 cells by the most effective phenothiazine derivative 3j. M627: 12H-benzo[α]phenothiazine (positive control)
adenocarcinoma cells at 20 μM, however, its early apoptosis-
inducing activity was lower compared to that of the positive
control 12H-benzo[α]phenothiazine (Figure 3) (9).
Based on the ABCB1-modulating activity of the lead
compounds, six derivatives were selected for combination
studies with doxorubicin. Compound 3j had the highest FAR
value at 2 μM of 9.55, in addition, the other selected
derivatives had FAR values of between 4.97 and 8.77 at 2
μM. The lead compounds 1c, 3d, 3g, 3h, 3i, and 3j were
studied regarding their effect in combination with
doxorubicin. As shown in Table II, all compounds exhibited
synergistic activity with doxorubicin at the ratio of 12:1
(phenothiazine derivative:doxorubicin). It can be concluded
that the lead compound of the phenothiazine series was
compound 3j because this derivative was a very potent
ABCB1 modulator and apoptosis inducer, furthermore, it
showed synergism with the anticancer drug doxorubicin
against MDR colonic adenocarcinoma cells.
Discussion
Phenothiazines have proven to be a special group of
compounds with extraordinary anticancer (10, 12, 13, 14)
and antibacterial activities (4, 15). Besides their various
biochemical effects (16), phenothiazines may be promising
candidates for combined anticancer chemotherapy (17).
The investigated N-hydroxyalkyl-2-aminophenothiazines
show promising antiproliferative and cytotoxic effects on
MDR colonic adenocarcinoma cells. The type of
substituents used in their synthesis can strongly influence
the anticancer activity of the derivatives. From our
understanding of the relationship between structural
diversity and activity, we have concluded that the
compounds substituted with secondary amines
(morpholine, diethylamine or N-methylpiperazine) in the
second position of the phenothiazine ring (3c, 3d, 3f) are
the most selective candidates. Furthermore, the oxidation
state of the sulfur atom (sulfoxide or sulfone) leads to
remarkable selectivity (3h, 3i, 3j) according to their IC50
data. The compounds containing primary amines or acid
amide in the second position of the ring, such as 1c, 1h,
1j, 1m, 1n resulted in lower activity compared to the
aforementioned molecules. It can be assumed that the
modulation of similar structural details (secondary amines
in the second position, 2-hydroxyl group in the alkyl chain,
sulfoxide or sulfone) of the chosen lead compounds (1c,
3d, 3g, 3h, 3i, 3j) is responsible for the efficacy of their
ABCB1 modulatory role and synergism with doxorubicin.
According to the cytotoxic and antiproliferative activity,
furthermore the ABCB1 modulating and apoptosis
inducing activity of the compounds, it can be observed that
the oxidation of sulfur atom of 1h resulted in the lead
molecule 3j. It can be concluded that this structural
modification increased the biological activity. To
understand this effect further binding assays could reveal
more biophysical and biochemical information on the
anticancer activity of these compounds.
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